We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-7.91%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$116M
AUM Growth
+$9.76M
Cap. Flow
+$11.9M
Cap. Flow %
10.25%
Top 10 Hldgs %
77.9%
Holding
189
New
31
Increased
1
Reduced
48
Closed
45

Top Buys

Rank Stock Value
1
SKYE icon
Skye Bioscience
SKYE
+$8.07M
2
INMB icon
INmune Bio
INMB
+$5.88M
3
GPATU
GP-Act III Acquisition Corp Units
GPATU
+$4.63M
4
AZZ icon
AZZ Inc
AZZ
+$3.22M
5
FSHPU
Flag Ship Acquisition Corp Unit
FSHPU
+$3.14M

Top Sells

Rank Stock Value
1
SPIR icon
Spire Global
SPIR
+$3.13M
2
ERAS icon
Erasca
ERAS
+$3M
3
SEDA
SDCL EDGE Acquisition Corporation
SEDA
+$2.55M
4
IBACU
IB Acquisition Corp. Unit
IBACU
+$2.5M
5
ACHV icon
Achieve Life Sciences
ACHV
+$2.39M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 46.25%
2 Miscellaneous 18.47%
3 Healthcare 15.17%
4 Financials 14.14%
5 Industrials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FORL
26
DELISTED
Four Leaf Acquisition Corp
FORL
$679K 0.59%
62,224
-12,224
-16% -$133K
TARA icon
27
Protara Therapeutics
TARA
$226M
$630K 0.54%
+302,746
New +$885K
GLAC
28
DELISTED
Global Lights Acquisition Corp Ordinary Shares
GLAC
$607K 0.52%
58,944
-22,899
-28% -$235K
ALUR
29
DELISTED
Allurion Technologies
ALUR
$520K 0.45%
+20,858
New +$961K
CHEB.U
30
DELISTED
Chenghe Acquisition II Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
CHEB.U
$501K 0.43%
+50,000
New +$501K
CCIXU
31
DELISTED
Churchill Capital Corp IX Unit
CCIXU
$494K 0.43%
+48,900
New +$494K
BLRX
32
BioLineRX
BLRX
$11.4M
$462K 0.4%
+20,392
New +$547K
SCLX icon
33
Scilex Holding
SCLX
$38.2M
$410K 0.35%
6,074
– –
GODN
34
DELISTED
Golden Star Acquisition Corporation Ordinary Shares
GODN
$389K 0.34%
36,029
– –
GROY icon
35
Gold Royalty Corp
GROY
$769M
$353K 0.3%
+250,000
New +$445K
ACHV icon
36
Achieve Life Sciences
ACHV
$834M
$337K 0.29%
71,749
-495,443
-87% -$2.39M
NNAG
37
DELISTED
99 Acquisition Group Inc
NNAG
$257K 0.22%
24,516
-34,603
-59% -$361K
RTB
38
RTB Digital
RTB
$182M
$154K 0.13%
3,039
+2,683
+754% +$151K
INBS icon
39
Intelligent Bio Solutions
INBS
$7.14M
$153K 0.13%
7,984
-2,841
-26% -$72.7K
CLOER
40
DELISTED
Clover Leaf Capital Corp. Rights
CLOER
$127K 0.11%
570,458
– –
NXL icon
41
Nexalin Technology
NXL
$214K
$93.7K 0.08%
+55,462
New +$81.6K
BWAQR
42
DELISTED
Blue World Acquisition Corporation Right
BWAQR
$70.4K 0.06%
350,000
– –
AEHL icon
43
Antelope Enterprise Holdings
AEHL
$4.02M
$67.8K 0.06%
+7
New +$47.9K
TENKR
44
DELISTED
TenX Keane Acquisition Right
TENKR
$64.2K 0.06%
199,000
– –
BDSX icon
45
Biodesix
BDSX
$283M
$59K 0.05%
+1,927
New +$55K
SURGW
46
DELISTED
SurgePays, Inc. Warrant
SURGW
$52.9K 0.05%
197,185
– –
TNONW icon
47
Tenon Medical Inc Warrant
TNONW
$2.03K
$49.9K 0.04%
999,400
– –
IMAQR
48
DELISTED
International Media Acquisition Corp. Rights
IMAQR
$47.8K 0.04%
1,200,000
– –
GROY.WS icon
49
Gold Royalty Corp Warrants
GROY.WS
$234M
$47.5K 0.04%
+250,000
New +$44.5K
BJDX icon
50
Bluejay Diagnostics
BJDX
$931K
$46.3K 0.04%
+331
New +$278K
1
2
3 4 5

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q2 2024 Portfolio in Review

As of Q2 2024, CVI Holdings held 189 positions worth $116M, up 9.2% from $106M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

CVI Holdings deployed $11.9M of net new capital in Q2 2024, opening 31 new positions and adding to 1 existing holding. Its largest new stake was Skye Bioscience: 84,967 shares worth $5.44M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, down from 55% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Achieve Life Sciences, an estimated $2.39M trimmed.

  • CVI Holdings's largest Q2 2024 buy was Skye Bioscience: 84,967 shares worth $5.44M.
  • CVI Holdings added most to RTB Digital in Q2 2024, an estimated $151K increase.
  • CVI Holdings's biggest Q2 2024 reduction was Achieve Life Sciences, cutting an estimated $2.39M.
  • CVI Holdings fully exited Spire Global in Q2 2024, selling an estimated $3.13M.
  • CVI Holdings's ten largest holdings make up 78% of its $116M portfolio in Q2 2024.
  • CVI Holdings opened 31 new positions and closed 45 in Q2 2024.
  • CVI Holdings's portfolio value rose 9.2% quarter-over-quarter to $116M.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.